The Food and Drug Administration issued a warning last month to General Electric Company healthcare unit telling it to “take prompt action to correct the violations” regarding manufacturing problems found upon inspections of an Ohio plant, Reuters reports.
Specifically, shortcomings were found at one GE Healthcare Technologies’ site in Aurora, Ohio. The site manufactures coils used in MRI systems and breast biopsy plates.
According to Reuters, The violations involved problems in assuring that only devices approved for release were actually shipped out. In addition, the FDA found that employees at the site did not respond and remedy complaints fast enough.
GE has responded to the FDA findings and said that it takes them very seriously and is seeking to resolve the identified problems as quickly as possible, Reuters reports.